Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials-Reference-Cited by-同舟云学术

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Published:2009-09 Issue:9694 Volume:374 Page:989-997
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

O'Donoghue Michelle L,Braunwald Eugene,Antman Elliott M,Murphy Sabina A,Bates Eric R,Rozenman Yoseph,Michelson Alan D,Hautvast Raymond W,Ver Lee Peter N,Close Sandra L,Shen Lei,Mega Jessica L,Sabatine Marc S,Wiviott Stephen D

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease;Jernberg;Eur Heart J,2006

2. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation;Brandt;Am Heart J,2007

3. Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

4. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents;Bhatt;Circulation,2008

5. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin;Gilard;J Thromb Haemost,2006

Cited by 607 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

2. Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation;BMC Medicine;2024-08-15

3. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?;Expert Opinion on Drug Metabolism & Toxicology;2024-07-15

4. From Atherosclerotic Plaque to Myocardial Infarction—The Leading Cause of Coronary Artery Occlusion;International Journal of Molecular Sciences;2024-07-02

5. 2023 ESC Guidelines for the management of acute coronary syndromes;European Heart Journal: Acute Cardiovascular Care;2023-09-22